Skip to main content
Clinical Trials/NCT00608296
NCT00608296
Completed
N/A

Functional and Neurochemical Brain Changes Following Successful Treatment of Early Course Bipolar Depression

University of Cincinnati1 site in 1 country120 target enrollmentJanuary 2008

Overview

Phase
N/A
Intervention
Not specified
Conditions
Depression, Bipolar
Sponsor
University of Cincinnati
Enrollment
120
Locations
1
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving quetiapine or lithium, in order to better understand who benefits from treatment and why they respond to medications.

Registry
clinicaltrials.gov
Start Date
January 2008
End Date
July 2013
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Caleb M. Adler

Associate Professor

University of Cincinnati

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials